Streetbeat News

Equity Actions

COHR

Needham analyst James Ricchiuti reiterated a Buy rating on Coherent Corp (COHR) with a $50 price target. This follows the announcement that DENSO and Mitsubishi Electric will each invest $500 million in COHR's SiC business for a 12.5% stake. The agreement allows COHR to raise up to $500 million from additional partners in the new SiC subsidiary for six months following the close of the transaction in Q1CY24. The $1 billion combined investment in the SiC subsidiary is expected to free up resources for debt reduction.

Portfolio Pulse from Shivani Kumaresan

October 11, 2023 | 7:42 pm

HD

A significant bearish stance has been taken on Home Depot (NYSE:HD) by a whale investor. Out of the 10 unusual trades detected, 90% were bearish and 10% bullish. The total amount for puts was $141,980 and for calls was $496,088. The targeted price range for Home Depot over the last 3 months has been $180.0 to $315.0. The current price of HD is up 0.27% at $300.02. HSBC has downgraded its action to Hold with a price target of $365, while Telsey Advisory Group and Truist Securities maintain their Market Perform and Buy ratings respectively.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:18 pm

BCO

NCR

NCR Corporation's shares are trading higher following reports of a potential merger of its ATM business with Brink's Co., despite Brink's denying the speculation. NCR's CEO, Michael D. Hayford, is also retiring following the successful separation of NCR into NCR Atleos and NCR Voyix. The stock experienced above-average trading volume.

Portfolio Pulse from Ryan Gustafson

October 11, 2023 | 7:02 pm

GS

A significant bullish stance has been taken on Goldman Sachs Gr (NYSE:GS) as indicated by unusual options activity. The sentiment among big-money traders is split between 54% bullish and 45% bearish. Whales have been targeting a price range from $290.0 to $425.0 for Goldman Sachs Gr over the last 3 months. The price of GS is up 0.55% at $316.5. Analysts from Oppenheimer, Citigroup, Morgan Stanley, and JMP Securities have maintained their ratings on Goldman Sachs Gr with price targets ranging from $329 to $450.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:01 pm

PLUG

Plug Power CEO Andy Marsh appeared on CNBC to discuss the company's projections and the day's stock movement following revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 6:53 pm

LRCX

A significant investor has taken a bearish stance on Lam Research (NASDAQ:LRCX), with 63% of recent trades being bearish. The targeted price range for Lam Research over the last 3 months is $530.0 to $645.0. The current price of LRCX is up 0.72% at $638.94. Wolfe Research has downgraded its action to Outperform with a price target of $825, while UBS maintains their Buy rating with a price target of $725.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:46 pm

ABBV

A significant bearish stance has been taken on AbbVie (NYSE:ABBV) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 8% bullish and 91% bearish. The whales have been targeting a price range from $55.0 to $150.0 for AbbVie over the last 3 months. Morgan Stanley maintains an Overweight rating on AbbVie with a price target of $193, while Raymond James downgraded its action to Outperform with a price target of $177.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:46 pm

EL

Estee Lauder Cos Inc. (NYSE:EL) has seen a 0.47% increase in the current market session, but an 8.52% decrease over the past month and a 34.63% decrease over the past year. The company's P/E ratio of 50.42 is higher than the Personal Products industry average of 36.93, which could indicate that the stock is overvalued or that it might perform better than its industry group.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:30 pm

DELL

Investor Business Daily's SwingTrader has reportedly purchased Dell Technologies' stock, according to traders' discussions.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 6:25 pm

MRMD

MariMed Inc. (OTC:MRMD) has expanded its retail footprint with the opening of an adult-use Thrive dispensary in Casey, Illinois. This is the fifth dispensary in Illinois and the 12th in MariMed’s portfolio across five states. The company also plans to commence operations at its processing facility in Mt. Vernon, Illinois in the fourth quarter, and anticipates the completion of its cultivation facility in early 2024. MariMed operates five of the state’s 130 licensed cannabis dispensary locations.

Portfolio Pulse from The Dales Report

October 11, 2023 | 6:20 pm